Lec 3
Molecular Basis of Diseases - CANCER
Introduction to Cancer
Cancer is a disease characterized by uncontrolled cell growth that can spread throughout the body.
It can originate from almost any cell type in the human body consisting of trillions of cells.
Normal cell division involves growth, replacement of old or damaged cells; cancer disrupts this orderly process.
Tumors
Tumors can be cancerous (malignant) or non-cancerous (benign).
Cancerous tumors invade nearby tissues and can metastasize to distant sites.
Many cancers form solid tumors, except for blood cancers (e.g., leukemias).
Differences between Cancer Cells and Normal Cells
Cancer cells grow without external signals; normal cells need these signals.
Cancer cells ignore stop signals, invade other areas, and hijack the blood supply for nutrients.
They can evade the immune system and accumulate genetic changes leading to uncontrolled growth.
How Does Cancer Develop?
Cancer is primarily a genetic disease caused by alterations in genes regulating cell function.
Genetic changes may arise from:
Errors during cell division.
Environmental damage (e.g., from tobacco, UV rays).
Hereditary factors.
Risk of cancer increases with age due to reduced capacity to eliminate damaged cells.
Tumor Microenvironment
Involves various immune cells, fibroblasts, and blood vessels that influence tumor growth and spread.
Types of Genes that Cause Cancer
Proto-oncogenes: Normal role in cell growth; mutations can lead to cancer-causing oncogenes.
Tumor Suppressor Genes: Control cell division; mutations can lead to uncontrolled growth.
DNA Repair Genes: Fix DNA errors; mutations result in further genetic instability.
Metastasis
Metastatic cancer retains the name of the original cancer (e.g., metastatic breast cancer in lungs).
Non-Cancerous Tissue Changes
Hyperplasia: Increased cell number with normal appearance.
Dysplasia: Abnormal cell appearance with potential for cancer development.
Carcinoma in situ: Abnormal cells that do not invade but may become cancerous.
Types of Cancer
Carcinoma: Common, arising from epithelial cells (e.g., adenocarcinoma).
Sarcoma: Forms in bone and soft tissues (e.g., osteosarcoma).
Leukemia: Bone marrow cancers not forming solid tumors; abnormal white blood cells dominate.
Lymphoma: Begins in lymphocytes; includes Hodgkin and non-Hodgkin lymphoma.
Multiple Myeloma: Arises in plasma cells; leads to bone tumors.
Melanoma: Starts in melanocytes; can occur on skin or in pigmented tissues.
Brain and Spinal Cord Tumors: Named based on the cell type in the CNS.
Germ Cell Tumors: Form from reproductive cells; can be benign or malignant.
Neuroendocrine Tumors: Release hormones and can be benign or malignant.
Hallmarks of Cancer
Key characteristics driving tumor growth include:
Sustained proliferative signaling
Evasion of growth suppressors
Resistance to cell death
Replicative immortality
Angiogenesis and invasion/migration of cancer cells
Oncogenes and Tumor Suppressor Genes
Oncogenes promote excessive growth when activated (point mutations, amplifications).
Tumor suppressor genes inhibit cell proliferation; inactivation contributes to tumor development.
Genetic and Epigenetic Alterations in Cancer
Genetic alterations include point mutations, translocations, and amplifications affecting gene function.
Epigenetic changes (DNA methylation, histone modifications) affect gene expression without altering sequence.
Non-coding RNAs can also play a role in regulating cancer-related processes.
Targeted Therapies for Cancer
Kinase Inhibitors and Monoclonal Antibodies: Target specific proteins or pathways (e.g., trastuzumab for HER2-positive breast cancer).
Emerging Therapies: Include PARP inhibitors and immunotherapies utilizing the immune system against cancer.
Personalized Medicine: Tailors treatment based on individual genetic profiles.